View Item 

Show simple item record

A Failed Future
dc.contributor.authorAlbin, Roger L.
dc.contributor.authorKordower, Jeffrey H.
dc.date.accessioned2020-09-02T15:00:41Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-09-02T15:00:41Z
dc.date.issued2020-08
dc.identifier.citationAlbin, Roger L.; Kordower, Jeffrey H. (2020). "A Failed Future." Movement Disorders 35(8): 1299-1301.
dc.identifier.issn0885-3185
dc.identifier.issn1531-8257
dc.identifier.urihttps://hdl.handle.net/2027.42/156468
dc.publisherJohn Wiley & Sons, Inc.
dc.titleA Failed Future
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156468/2/mds28130.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/156468/1/mds28130_am.pdfen_US
dc.identifier.doi10.1002/mds.28130
dc.identifier.sourceMovement Disorders
dc.identifier.citedreferenceBachoud‐Levi AC. From open to large‐scale randomized cell transplantation trials in Huntington’s disease: lessons from the multicentric intracerebral grafting in Huntington’s disease trial (MIG‐HD) and previous pilot studies. Prog Brain Res 2017; 230: 227 – 261.
dc.identifier.citedreferenceFreeman TB, Cicchetti F, Hauser RA, et al. Transplanted fetal striatum in Huntington’s disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 2000; 97: 13877 – 13882.
dc.identifier.citedreferenceCisbani G, Maxan A, Kordower JH, Planel E, Freeman TB, Cicchetti F. Presence of tau pathology within foetal neural allografts in patients with Huntington’s and Parkinson’s disease. Brain 2017; 140: 2982 – 2992.
dc.identifier.citedreferenceCisbani G, Freeman TB, Soulet D, et al. Striatal allografts in patients with Huntington’s disease: impact of diminished astrocytes and vascularization on graft viability. Brain 2013; 136: 433 – 443.
dc.identifier.citedreferenceGallina, P, Paganini, M, Lombardini, L, et al. Human striatal neuroblasts develop and build a striatal‐like structure into the brain of Huntington’s disease patients after transplantation. Exp Neurol 2010; 222: 30 – 36.
dc.identifier.citedreferenceFreeman TB, Cicchetti F, Bachoud‐Lévi AB, Dunnett SB. Technical factors that influence neural transplant safety in Huntington’s disease. Exp Neurol 2011; 227: 1 – 9.
dc.identifier.citedreferenceKrebs SS, Trippel M, Prokop T, et al. Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington’s disease: consequences of cerebral transplantation programs. Clin Exp Neuroimmunol 2011; 2: 25 – 32.
dc.identifier.citedreferenceBankiewicz KS, Sudhakar V, Samaranch L, San Sebastian W, Bringas J, Forsayeth J. AAV viral vector delivery to the brain by shape‐conforming MR‐guided infusions. J Control Release 2016; 240: 434 – 442.
dc.identifier.citedreferenceKordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N Engl J Med 1995; 332: 1118 – 1125.
dc.identifier.citedreferenceKordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body‐like pathology in long‐term embryonic nigral transplants in Parkinson’s disease. Nat Med 2008; 14: 504 – 506.
dc.identifier.citedreferenceKordower JH, Goetz CG, Chu Y, et al. Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient. Ann Neurol 2017; 81: 46 – 57.
dc.identifier.citedreferenceLi JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host‐to‐graft disease propagation. Nat Med 2008; 14: 501 – 503.
dc.identifier.citedreferenceLi W, Englund E, Widner H, et al. Extensive graft‐derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc Natl Acad Sci U S A 2016; 113: 6544 – 6549.
dc.identifier.citedreferenceVeldman MB, Yang XW. Molecular insights into cortico‐striatal miscommunications in Huntington’s disease. Curr Opin Neurobiol 2018; 48: 79 – 89.
dc.identifier.citedreferenceEdgerton D. The Shock of the Old: Technology and Global History Since 1900. London: Oxford University Press; 2011.
dc.identifier.citedreferenceBachoud‐Levi AC, Remy P, Audureau E, et al. Human fetal cell therapy in Huntington’s disease: a randomized, multicenter, phase II trial (MIG‐HD). Mov Disord 2020. In press.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
mds28130_am.pdf
Size:
353.8KB
Format:
PDF
View/Open
Name:
mds28130.pdf
Size:
69.58KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.